Viewing Study NCT02663518

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:42 AM
Ignite Modification Date: 2026-02-27 @ 8:27 AM
Study NCT ID: NCT02663518
Status: TERMINATED
Last Update Posted: 2024-05-10
First Post: 2016-01-19
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematologic Malignancies View
None Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PF-07901800 View
None ABCL View
None Aggressive B-cell lymphoma View
None CLL View
None Chronic lymphocytic leukemia View
None CTCL View
None Cutaneous T-Cell Lymphoma View
None HL View
None Hodgkin lymphoma View
None IBCL View
None Indolent B-cell lymphoma View
None MDS View
None Myelodysplastic syndromes View
None MPN View
None Myeloproliferative neoplasms View
None MM View
None Multiple Myeloma View
None PTCL View
None Peripheral T-cell lymphomas View
None SCLC View
None Small Cell Lung Cancer View
None T-cell lymphoma View
None Rituximab View
None Nivolumab View
None TTI-621 View
None Solid Tumor View
None Hematologic Malignancies View
None Lymphoma View
None CD47 View
None SIRPĪ±-IgG1 Fc View